MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders

British Journal of Haematology

Volumn 102, Issue 3, 1998, Pages 710-717

  Webb, M ^a,b   Brun, M ^b   Mcniven, M ^b   Le Couteur, D ^a,b   Craft, P ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CANBERRA HOSPITAL   (Australia)

Author keywords

CLL; MDR1; MRP; NHL; P glycoprotein

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; PREDNISOLONE; VINCRISTINE;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONTROLLED STUDY; DRUG TRANSPORT; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATP-BINDING CASSETTE TRANSPORTERS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; GENES, MDR; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LYMPHOMA, LOW-GRADE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN;

EID: 0031839821     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00822.x     Document Type: Article

References (22)

1. Bailar, J.C. & Mosteller, F. (1992) Medical Uses of Statistics, pp. 247-250. NEJM Books, Boston.
2. Beck, J., Niethammer, D. & Gekeler, V. (1994) High mdr1 and mrp, but low topoisomerase 11 alpha-gene expression in B-cell chronic lymphocytic leukaemias. Cancer Letters, 86, 135-142.
3. Beck, W., Muellar, T. & Tanzer, L. (1979) Altered surface membrane glycoproteins in vincristine alkaloids-resistant human leukaemic lymphoblasts. Cancer Research, 39, 2070-2076.
4. Burger, H., Nooter, K., Sonneveld, P., Van Wingerden, K.E., Zaman, G.J.R. & Stoter, G. (1994) High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia. British Journal of Haematology, 88, 348-356.
5. Cole, S., Bhardwaj, G., Gerlach, J., Mackie, J., Grant, C., Almquist, K., Stewart, A., Kurz, E., Duncan, A. & Deeley, R. (1992) Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science, 258, 1650-1654.
6. Grant, C.E., Valdimarsson, G., Hipfner, D.R., Almquist, K.C., Cole, S.P.C. & Deeley, R.G. (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Research, 54, 557-361.
7. Gros, P., Ben Neriah, Y., Croop, J.M. & Housman, D.E. (1986) Isolation and expression of a cDNA (mdr) that confers multidrug resistance. Nature, 323, 728-751.
8. Hipfner, D.R., Gauldie, S.D., Deeley, R.G. & Cole, S.P. (1994) Detection of M(r) 190,000 multidrug resistance, MRP with monoclonal antibodies. Cancer Research, 54, 5788-5792.
9. Holmes, J.A., Jacobs, A., Carter, G., Whittaker, J.A., Bentley, D.P. & Padua, R.A. (1990) Is the mdr 1 gene relevant in chronic lymphocytic leukemia? Leukemia, 4, 216-218.
10. Islam, D., Lindberg, A. & Christensson, B. (1995) Peripheral blood cell preparation influence's the level of expression of leukocyte cell surface markers as assessed with quantitative multicolor flow cytometry. Cytometry, 22, 128-34.
11. Ludescher, C., Hilbe, W., Eisterer, W., Preuss, E., Huber, C., Gotwald, M., Hofman, J. & Thaler. J. (1995) Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometry assay. Journal of the National Cancer Institute, 85, 1751-1758.
12. Michieli, M., Raspadori, D., Damiani, D., Geromin, A., Gallizia, C., Michelutti, A., Fanin, R., Fasola, G., Russo, D., Tazzari, P., Pileri, S., Mallardi, F. & Baccarani, M. (1991) The expression of the multidrug resistance-associated glycoprotein in 15-cell chronic lymphocytic leukaemia. British Journal of Haematology, 77, 460-465.
13. Peters, R., Janossy, G., Ivory, K., al-Ismail, S. & Mereolino, T. (1996) Leukemia-associated changes identified by quantitative flow cytometry: B-cell gating in CD37/kappa/lambda clonality test. Leukemia, 8, 1864-70.
14. Ribrag, V. Massade, L., Faussat, A.M., Dreyfus, F., Bayle, C., Gouyette, A. & Marie, J.P. (1996) Drug resistance mechanisms in chronic lymphocytic leukemia. Leukemia, 10, 1944-1949.
15. Shustik, C., Groulx, N. & Gros, P. (1991) Analysis of multidrug resistance (MDR-1) gene expression in chronic lymphocytic leukaemia (CLL). British Journal of Haematology, 79, 50-56.
16. 3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia. Blood. 79, 1496-1500.
17. Sparrow, R.L., Hall, F.J., Siregar, H. & Van der Weyden, M.B. (1993) Common expression of the multidrug resistance marker P-glycoprotein in 13-cell chronic lymphoproliferative leukemia and correlation with in vitro drug resistance. Leukemia Research, 17, 941-947.
18. Ueda, K., Cornwell, M.M., Gottesman, M.M., Pastan, L. Roninson, I.B., Ling, V. & Riordan, J.R. (1986) The mdr1 gene, responsible for multidrug resistance, codes for P-glycoprotein. Biochemical and Biophysical Research Communications, 141, 956-962.
19. Wallner, J., Gisslinger, H., Gisslinger, B., Gsur, A., Gotzl, M., Zochbauer, S. & Pirker, R. (1994) MDR1 gene expression in chronic lymphocytic leukaemia. Leukaemia and Lymphoma, 13, 333-358.
20. Webb, M., Raphael, C., Asbahr, H., Erber, W.N. & Meyer, B. (1996) The detection of rhodamine 125 efflux at low levels of drug resistance. British Journal of Haematology, 93, 650-655.
21. Wulf, G., Kluding, H., Ho, A.D., Doerner, M., Doehner, H., Manegold, C. & Hunstein, W. (1994) Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and Northern blot analysis. Leukemia Research, 18, 475-484.
22. Zaman, G.J.R., Flens, M.J., Van Leusden, M.R., de Hass, M., Mulder, H.S., Lankelma, J., Pinedo, H.M., Scheper, R.J., Baas, F., Broxterman, H.J. & Borst, P. (1994) The human multidrug resistance-associated protein (MRP) is a plasma membrane drug efflux pump. Proceedings of the National Academy of Sciences of the United States of America, 91, 8822-8826.